Health Technology Assessment in Action

Published by: Kowsar

Safety and Efficacy of Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Review and Meta-Analysis

Nabi Shariatifar 1 , Bahman Amani ORCID 2 , * , Behnam Amani 2 , Arash Akbarzadeh 3 , Rouhollah Shabestan 3 and Farhad Azadi 4
Authors Information
1 Department of Environmental Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Health Sciences Education Development, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Physical Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
Article information
  • Health Technology Assessment in Action: April 30, 2018, 2 (1); e93518
  • Published Online: June 22, 2019
  • Article Type: Systematic Review
  • Received: May 13, 2019
  • Revised: June 15, 2019
  • Accepted: June 18, 2019
  • DOI: 10.5812/htaa.93518

To Cite: Shariatifar N , Amani B, Amani B, Akbarzadeh A, Shabestan R, et al. Safety and Efficacy of Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Review and Meta-Analysis, Health Tech Asmnt Act. 2018 ; 2(1):e93518. doi: 10.5812/htaa.93518.

Copyright © 2019, Health Technology Assessment in Action. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Gokce MI, Yaman O. Erectile dysfunction in the elderly male. Turk J Urol. 2017;43(3):247-51. doi: 10.5152/tud.2017.70482. [PubMed: 28861293]. [PubMed Central: PMC5562240].
  • 2. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572-88. doi: 10.1111/j.1743-6109.2010.02062.x. [PubMed: 21040491].
  • 3. Qiu X, Lin G, Xin Z, Ferretti L, Zhang H, Lue TF, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10(3):738-46. doi: 10.1111/jsm.12024. [PubMed: 23253086]. [PubMed Central: PMC3593747].
  • 4. Ruffo A, Capece M, Prezioso D, Romeo G, Illiano E, Romis L, et al. Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction. Int Braz J Urol. 2015;41(5):967-74. doi: 10.1590/S1677-5538.IBJU.2014.0386. [PubMed: 26689523]. [PubMed Central: PMC4756974].
  • 5. Peyton CC, Colaco MA, Kovell RC, Kim JH, Terlecki RP. Erectile dysfunction is predictive of endothelial dysfunction in a well visit population. J Urol. 2016;195(4 Pt 1):1045-50. doi: 10.1016/j.juro.2015.11.037. [PubMed: 26614890].
  • 6. Bozorgmehri S, Fink HA, Parimi N, Canales B, Ensrud KE, Ancoli-Israel S, et al. Association of sleep disordered breathing with erectile dysfunction in community dwelling older men. J Urol. 2017;197(3 Pt 1):776-82. doi: 10.1016/j.juro.2016.09.089. [PubMed: 27697577]. [PubMed Central: PMC5374724].
  • 7. Lei H, Liu J, Li H, Wang L, Xu Y, Tian W, et al. Low-intensity shock wave therapy and its application to erectile dysfunction. World J Mens Health. 2013;31(3):208-14. doi: 10.5534/wjmh.2013.31.3.208. [PubMed: 24459653]. [PubMed Central: PMC3888889].
  • 8. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12 Suppl 4:S6-S11. doi: 10.1038/sj.ijir.3900567. [PubMed: 11035380].
  • 9. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ, Urologic Diseases in America P. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207-12. doi: 10.1001/archinte.166.2.207. [PubMed: 16432090].
  • 10. Garimella PS, Paudel ML, Ensrud KE, Marshall LM, Taylor BC, Fink HA, et al. Association between body size and composition and erectile dysfunction in older men: Osteoporotic fractures in men study. J Am Geriatr Soc. 2013;61(1):46-54. doi: 10.1111/jgs.12073. [PubMed: 23311552]. [PubMed Central: PMC4028028].
  • 11. Angulo J, Gonzalez-Corrochano R, Cuevas P, Fernandez A, La Fuente JM, Rolo F, et al. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries. J Sex Med. 2010;7(2 Pt 1):758-68. doi: 10.1111/j.1743-6109.2009.01587.x. [PubMed: 19912487].
  • 12. Dorsey P, Keel C, Klavens M, Hellstrom WJ. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother. 2010;11(7):1109-22. doi: 10.1517/14656561003698131. [PubMed: 20402554].
  • 13. Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, et al. Pharmacotherapy for erectile dysfunction. J Sex Med. 2010;7(1 Pt 2):524-40. doi: 10.1111/j.1743-6109.2009.01627.x. [PubMed: 20092451].
  • 14. Dhir RR, Lin HC, Canfield SE, Wang R. Combination therapy for erectile dysfunction: An update review. Asian J Androl. 2011;13(3):382-90. doi: 10.1038/aja.2011.2. [PubMed: 21423198]. [PubMed Central: PMC3739353].
  • 15. Carvalheira AA, Pereira NM, Maroco J, Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: A study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med. 2012;9(9):2361-9. doi: 10.1111/j.1743-6109.2012.02787.x. [PubMed: 22616766].
  • 16. Hakim L, Van der Aa F, Bivalacqua TJ, Hedlund P, Albersen M. Emerging tools for erectile dysfunction: A role for regenerative medicine. Nat Rev Urol. 2012;9(9):520-36. doi: 10.1038/nrurol.2012.143. [PubMed: 22824778].
  • 17. Bechara A, Casabe A, De Bonis W, Ciciclia PG. Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors. Sex Med. 2016;4(4):e225-32. doi: 10.1016/j.esxm.2016.06.001. [PubMed: 27444215]. [PubMed Central: PMC5121537].
  • 18. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012;9(1):259-64. doi: 10.1111/j.1743-6109.2011.02498.x. [PubMed: 22008059].
  • 19. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187(5):1769-75. doi: 10.1016/j.juro.2011.12.117. [PubMed: 22425129].
  • 20. Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, et al. Pharmacotherapy for erectile dysfunction: Recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J Sex Med. 2016;13(4):465-88. doi: 10.1016/j.jsxm.2016.01.016. [PubMed: 27045254].
  • 21. Loeb S, Folkvaljon Y, Lambe M, Robinson D, Garmo H, Ingvar C, et al. Use of phosphodiesterase type 5 inhibitors for erectile dysfunction and risk of malignant melanoma. JAMA. 2015;313(24):2449-55. doi: 10.1001/jama.2015.6604. [PubMed: 26103029].
  • 22. Hatzichristou D, d'Anzeo G, Porst H, Buvat J, Henneges C, Rossi A, et al. Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urol. 2015;15:111. doi: 10.1186/s12894-015-0107-5. [PubMed: 26563171]. [PubMed Central: PMC4643510].
  • 23. Bai Y, Zhang L, Jiang Y, Ju J, Li G, Xu J, et al. Identification and functional verification of microRNAs in the obese rat with erectile dysfunction. Sex Med. 2017;5(4):e261-71. doi: 10.1016/j.esxm.2017.06.006. [PubMed: 28970082]. [PubMed Central: PMC5693398].
  • 24. Hazan-Molina H, Reznick AZ, Kaufman H, Aizenbud D. Periodontal cytokines profile under orthodontic force and extracorporeal shock wave stimuli in a rat model. J Periodontal Res. 2015;50(3):389-96. doi: 10.1111/jre.12218. [PubMed: 25073624].
  • 25. Becker M, Goetzenich A, Roehl AB, Huebel C, de la Fuente M, Dietz-Laursonn K, et al. Myocardial effects of local shock wave therapy in a Langendorff model. Ultrasonics. 2014;54(1):131-6. doi: 10.1016/j.ultras.2013.07.005. [PubMed: 23896623].
  • 26. Hayashi D, Kawakami K, Ito K, Ishii K, Tanno H, Imai Y, et al. Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: A critical role of endothelial nitric oxide synthase. Wound Repair Regen. 2012;20(6):887-95. doi: 10.1111/j.1524-475X.2012.00851.x. [PubMed: 23110611].
  • 27. Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res. 2012;7:11. doi: 10.1186/1749-799X-7-11. [PubMed: 22433113]. [PubMed Central: PMC3342893].
  • 28. Yee CH, Chan ES, Hou SS, Ng CF. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double-blinded, placebo controlled study. Int J Urol. 2014;21(10):1041-5. doi: 10.1111/iju.12506. [PubMed: 24942563].
  • 29. Olsen AB, Persiani M, Boie S, Hanna M, Lund L. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. Scand J Urol. 2015;49(4):329-33. doi: 10.3109/21681805.2014.984326. [PubMed: 25470423].
  • 30. Fode M, Lowenstein L, Reisman Y. Low-intensity extracorporeal shockwave therapy in sexual medicine: A questionnaire-based assessment of knowledge, clinical practice patterns, and attitudes in sexual medicine practitioners. Sex Med. 2017;5(2):e94-8. doi: 10.1016/j.esxm.2016.12.002. [PubMed: 28268167]. [PubMed Central: PMC5440640].
  • 31. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1. [PubMed: 25554246]. [PubMed Central: PMC4320440].
  • 32. Srini VS, Reddy RK, Shultz T, Denes B. Low intensity extracorporeal shockwave therapy for erectile dysfunction: A study in an Indian population. Can J Urol. 2015;22(1):7614-22. [PubMed: 25694008].
  • 33. Kitrey ND, Gruenwald I, Appel B, Shechter A, Massarwa O, Vardi Y. Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: A double-blind, sham controlled study. J Urol. 2016;195(5):1550-5. doi: 10.1016/j.juro.2015.12.049. [PubMed: 26694904].
  • 34. Fojecki GL, Tiessen S, Osther PJ. Effect of low-energy linear shockwave therapy on erectile dysfunction-a double-blinded, sham-controlled, randomized clinical trial. J Sex Med. 2017;14(1):106-12. doi: 10.1016/j.jsxm.2016.11.307. [PubMed: 27938990].
  • 35. Kalyvianakis D, Hatzichristou D. Low-intensity shockwave therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: A triplex ultrasonography-based sham-controlled trial. J Sex Med. 2017;14(7):891-7. doi: 10.1016/j.jsxm.2017.05.012. [PubMed: 28673433].
  • 36. Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF. Low-intensity extracorporeal shock wave treatment improves erectile function: A systematic review and meta-analysis. Eur Urol. 2017;71(2):223-33. doi: 10.1016/j.eururo.2016.05.050. [PubMed: 27321373].
  • 37. Zhang L, Weng C, Zhao Z, Fu X. Extracorporeal shock wave therapy for chronic wounds: A systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2017;25(4):697-706. doi: 10.1111/wrr.12566. [PubMed: 28759136].
  • 38. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-41. doi: 10.1016/j.juro.2018.05.004. [PubMed: 29746858].
  • 39. Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. 46. European Association of Urology; 2016.
  • 40. Zhang L, Fu XB, Chen S, Zhao ZB, Schmitz C, Weng CS. Efficacy and safety of extracorporeal shock wave therapy for acute and chronic soft tissue wounds: A systematic review and meta-analysis. Int Wound J. 2018;15(4):590-9. doi: 10.1111/iwj.12902. [PubMed: 29675986].
  • 41. Schmitz C, Csaszar NB, Milz S, Schieker M, Maffulli N, Rompe JD, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: A systematic review on studies listed in the PEDro database. Br Med Bull. 2015;116:115-38. doi: 10.1093/bmb/ldv047. [PubMed: 26585999]. [PubMed Central: PMC4674007].
  • 42. Korakakis V, Whiteley R, Tzavara A, Malliaropoulos N. The effectiveness of extracorporeal shockwave therapy in common lower limb conditions: A systematic review including quantification of patient-rated pain reduction. Br J Sports Med. 2018;52(6):387-407. doi: 10.1136/bjsports-2016-097347. [PubMed: 28954794].
  • 43. Zissler A, Stoiber W, Pittner S, Sänger AM. Extracorporeal shock wave therapy in acute injury care: A systematic review. Rehabil Process Outcome. 2018;7:1.1795727187651E+14. doi: 10.1177/1179572718765138.
  • 44. Cayton T, Harwood A, Smith GE, Chetter I. A systematic review of extracorporeal shockwave therapy as a novel treatment for intermittent claudication. Ann Vasc Surg. 2016;35:226-33. doi: 10.1016/j.avsg.2016.02.017. [PubMed: 27311948].
  • 45. Punnoose A. Extracorporeal shock wave therapy for achilles and patellar tendinopathy: Meta-analysis and a systematic review of the literature. J Physiother Phys Rehabil. 2017;2(1). doi: 10.4172/2573-0312.1000124.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments